The ecotropic murine leukemia virus (E-MuLV) receptor expressed on Mus
dunni tail fibroblast (MDTF) cells is a receptor for all E-MuLVs with
the notable exception of Moloney murine leukemia virus (Mo-MuLV). Sub
stitution of isoleucine for valine at position 214 in the third extrac
ellular region (the putative E-MuLV binding site) of the MDTF receptor
molecule allows this molecule to function as a Mo-MuLV receptor (M. V
. Eiden, K. Farrell, J. Warsowe, L.A. Mahan, and C.A. Wilson, J. Virol
. 67:4056-4061, 1993). We have now determined that treating MDTF cells
with tunicamycin, an inhibitor of N-linked glycosylation, also render
s them susceptible to Mo-MuLV infection. Two potential N-linked glycos
ylation sites are present in the third extracellular regions of both t
he NIH 3T3 and MDTF ecotropic receptors. The glycosylation site at pos
ition 229 of the MDTF receptor cDNA was eliminated by substituting a t
hreonine codon for the asparagine codon. Mo-MuLV-resistant human HOS c
ells, expressing this form of the receptor, are susceptible to Mo-MuLV
infection. Thus, our studies suggest that without a glycan moiety at
position 229, the valine residue at 214 is no longer restrictive for M
o-MuLV infection. BHK-21 and CHO K1 hamster cells also express glycosy
lation-inactivated forms of the ecotropic receptor. Sequence analysis
of these receptors together with our analysis of MDTF receptor functio
n suggests that a single asparagine-linked glycosylation site is respo
nsible for glycosylation inactivation of these receptors.